What is the Status of the Agreement to Settle NuvaRing Injury Suits?



Thousands of women throughout the United States are currently pursuing a NuvaRing injury lawsuit after suffering a stroke, heart attack, pulmonary embolism, deep vein thrombosis (DVT) or other blood clot injury. All of the claims involve similar allegations that Merck and their Organon subsidiary failed to adequately warn consumers and the medical community about the potential side effects of the birth control ring.

Please note that the lawyers at Saiontz & Kirk, P.A. are no longer taking on new cases involving NuvaRing. The content on this page is provided for informational purposes only.

On February 7, 2014, it was announced that Merck has offered a lump sum amount of $100 million to settle the entire NuvaRing litigation.

Under terms of the proposed agreement, 95% of all eligible claimants must agree to participate in the settlement program or Merck has the option of walking away from the deal. In addition, certain participation thresholds are required for specific types of claims.

This is a nationwide settlement offer, which would include all cases filed as of the date the agreement was announced, as well as qualifying claimants who have not yet filed a lawsuit. In order to qualify for a portion of the settlement, each participant must meet certain requirements outlined in the Master Settlement Agreement for NuvaRing. The determination of individual claim values under the NuvaRing settlement will be made by a committee of plaintiffs’ counsel, pursuant to established criteria.

The settlement only applies to NuvaRing injuries that occurred prior to February 7, 2014, and for women who signed a retainer agreement with an attorney for legal representation relating to that injury prior to that date.

Eligible plaintiffs are able to settle their NuvaRing case by enrolling in the program, and agreeing to be bound by the terms of the settlement. Further details regarding this settlement will be provided to clients who retained Saiontz & Kirk, P.A. prior to February 7.

According to terms of the agreement, the “Opt-In Deadline” is March 10, 2014 at 11:59 p.m. C.T. A 15 day extension may be sought from the Claims Administrator for certain cases, with additional extensions possible by mutual agreement of the Defendants and Negotiating Plaintiffs’ Counsel.

Merck and their Organon subsidiary will then have until the 45th day following the last extension deadline to exercise any termination right under the agreement.

If the NuvaRing agreement moves forward for the qualifying claims, there will then be a lengthy process of submission and review of claims packages, as well as curing potential deficiencies in claim packages.

Austin Kirk

Last Updated August 13, 2013

8 Comments • Add Your Comments

  • Monica says:

    I had two cases of blood clots. And they won’t even pay mind to me about my medical condition. I was never notify about the nuvrea ring and it affects..

    Posted on December 29, 2015 at 10:27 pm

  • jessica says:

    It’s has been 4 years since I first filed the lawsuit .

    Posted on February 17, 2016 at 2:28 am

  • Jane says:

    Hi! I also am in the same boat as you
    I filed my claim in 2009 and still nothing
    I was told last year the amount awarded etc, that was in June
    So almost a year ago
    Now I can not get in touch with the law firm rep who is in charge of my case.
    Any advice??

    Posted on April 18, 2016 at 4:45 pm

  • Nicole says:

    I took Nuvaring in Feburary of 2015. After a couple of weeks, I suffered from extreme anxiety, depression, and constant mood swings. My stomach got very weak and I was constantly vomiting every meal. I was in and out of the hospital without any insurance. I am over worked with hospital bills. After a couple of months, I was hospitalized again for gastritis. I strongly believe Nuvaring made me very sick and weak. What should I do?

    Posted on November 19, 2016 at 6:46 pm

  • charlotte says:

    I have also tried to get help from this i was using the nuvaring back in 2008 maybe beginning of 2009 now i suffer from persudotumo and every day its a battle i have a constant headache and sometimes it gets so bad i actually have to go to hospital to take shot. Im on medicine due to this and suffer lots of pain. I have had fluid drained (lumbar puncture ) which put me down for almost a whole 2 weeks. I have 2 children and miss out alot of are daily routines due to this. I wish to hear back from someone. I have been to every sit u can think of and submitted for consultation.

    Posted on January 18, 2017 at 11:59 pm

  • Misty says:

    I took the birth control nuva ring
    Several years ago and the nuva ring
    Had got stuck couldn’t remove the nuva ring also since I had taken the nuva ring
    also depo shot I haven’t been able to
    concieve a child the birth control has
    literally left me stirille with no chance of
    Pregnancy I need to speak to an attorney
    I’ve been trying to concieve for years …

    Posted on August 14, 2017 at 7:08 pm

  • Katie says:

    Hi, I am suffering from the same thing as you Char, this is a nightmare I am hospitalized as I write this right now . This is so unbelievable

    Posted on December 29, 2017 at 12:34 am

  • Deborah says:

    I took the Nuvaring and I’ve extreme migraines, digestive issues, was hospitalized 2011 for four day where they found tumor on my liver, my skin has darkened I have melasma, keep vaginal discharge, developed horrible periods, etc, all documented and i’m still being treated for. How do I get involved in this lawsuit and am I able to get any restitution from the first settlement?

    Posted on December 8, 2018 at 12:19 pm

Add Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.